Skip to main content
. 2012 Jan 20;302(6):H1274–H1284. doi: 10.1152/ajpheart.01067.2011

Fig. 5.

Fig. 5.

A–C: effects of PKC activation, via topically applied phorbol 12,13-dibutyrate (PdBu, 10 nM), on pial arteriolar responses in experiments involving only nondiabetic control animals. PdBu markedly inhibited dilations induced by the BKCa agonist NS-1619 (A), the Kir agonist K+ (B), and SNS (C) (n = 5 for all, *P < 0.05 vs. initial responses).